320 Appendices List of publications 1. Blaauwgeers H, Lissenberg-Witte BI, Dickhoff C, Duin S, Thunnissen E. Prognostic value of proliferation, PD-L1 and nuclear size in patients with superior sulcus tumours treated with chemoradiotherapy and surgery. J Clin Pathol. 2023;76(2):111–5. 2. Blaauwgeers H, Radonic T, Lissenberg-Witte B, Bahce I, Vincenten J, Dickhoff C, et al. P06.02 Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study. J Thorac Oncol [Internet]. 2021;16(10):S985. Available from: https://doi.org/10.1016/j.jtho.2021.08.281 3. Butter R, Hondelink L, van Elswijk L, Blaauwgeers JLG, Bloemena E, Britstra R, et al. The impact of a pathologist’s personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer. Lung Cancer [Internet]. 2022;166(December 2021):143–9. Available from: https://doi.org/10.1016/j. lungcan.2022.03.002 4. Thunnissen E, Motoi N, Minami Y, Matsubara D, Timens W, Nakatani Y, Ishikawa Y, BaezNavarro X, Radonic T, Blaauwgeers H, Borczuk A and Noguchi M. Elastin in pulmonary pathology: relevance in tumours with a lepidic or papillary appearance. A comprehensive understanding from a morphological viewpoint. Vol. 80, Histopathology. John Wiley and Sons Inc; 2022. p. 457–67. 5. Blaauwgeers H, Thunnissen E. Spread Through Air Spaces (STAS): Can an Artifact Really be Excluded? Am J Surg Pathol. 2021 Jul;145(10):1439. 6. Theelen WSME, Krijgsman O, Monkhorst K, Kuilman T, Peters DDGC, Cornelissen S, Blaauwgeers H et al. Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma. J Transl Med [Internet]. 2020;18(1):1–12. Available from: https://doi.org/10.1186/s12967-020-02436-3 7. Thunnissen E, Marchevsky A, Rossi G, Russell PA, Blaauwgeers H, Radonic T, et al. RE: Spread Through Air Spaces (STAS) is Prognostic in Atypical Carcinoid, Large Cell Neuroendocrine Carcinoma, and Small Cell Carcinoma of the Lung. Vol. 15, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. United States; 2020. p. e116–7. 8. Wolf JL, van Nederveen F, Blaauwgeers H, Marx A, Nicholson AG, Roden AC, et al. Interobserver variation in the classification of thymic lesions including biopsies and resection specimens in an international digital microscopy panel. Histopathology. 2020;734–41. 9. Theelen WSME, Kuilman T, Schulze K, Zou W, Krijgsman O, Peters DDGC, Blaauwgeers H et al. Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNgamma signaling in non-small cell lung cancer. PLoS One. 2019;14(5):e0216864. 10. Blaauwgeers H, Damhuis R, Lissenberg-Witte BI, de Langen AJ, Senan S, Thunnissen E. A Population-Based Study of Outcomes in Surgically Resected T3N0 Non–Small Cell Lung Cancer in The Netherlands, Defined Using TNM-7 and TNM-8; Justification of Changes and an Argument to Incorporate Histology in the Staging Algorithm. J Thorac Oncol [Internet]. 2019;14(3):459–67. Available from: https://doi.org/10.1016/j.jtho.2018.10.164 11. Oja AE, Piet B, van der Zwan D, Blaauwgeers H, Mensink M, de Kivit S, et al. Functional Heterogeneity of CD4(+) Tumor-Infiltrating Lymphocytes With a Resident Memory Phenotype in NSCLC. Front Immunol. 2018;9:2654. 12. Blaauwgeers H, Russell PA, Jones KD, Radonic T, Thunnissen E. Pulmonary loose tumor tissue fragments and spread through air spaces (STAS): Invasive pattern or artifact? A critical review. Vol. 123, Lung Cancer. 2018. p. 107–11.
RkJQdWJsaXNoZXIy MTk4NDMw